International Journal of Clinical Case Reports 2024, Vol.14, No.3, 167-177 http://medscipublisher.com/index.php/ijccr 176 Guerra L., Bonetti L., and Brenner D., 2020, Metabolic modulation of immunity: a new concept in cancer immunotherapy, Cell Reports, 32(1): 107848. https://doi.org/10.1016/j.celrep.2020.107848 PMid:32640218 Hanna A., and Balko J., 2021, Breast cancer resistance mechanisms: challenges to immunotherapy, Breast Cancer Research and Treatment, 190(1): 5-17. https://doi.org/10.1007/s10549-021-06337-x PMid:34322780 PMCid:PMC8560575 Hegde P., and Chen D., 2020, Top 10 Challenges in cancer immunotherapy, Immunity, 52(1): 17-35. https://doi.org/10.1016/j.immuni.2019.12.011 PMid:31940268 Henriques B., Mendes F., and Martins D., 2021, Immunotherapy in breast cancer: when, how, and what challenges?, Biomedicines, 9(11): 1687. https://doi.org/10.3390/biomedicines9111687 PMid:34829916 PMCid:PMC8616011 Hu Y., Li Y., Yao Z., Huang F., Cai H., Liu H., Zhang X., and Zhang J., 2023, Immunotherapy: review of the existing evidence and challenges in breast cancer, Cancers, 15(3): 563. https://doi.org/10.3390/cancers15030563 PMid:36765522 PMCid:PMC9913569 Khalil D.N., Smith E.L., Brentjens R.J., and Wolchok J.D., 2016, The future of cancer treatment: immunomodulation, CARs and Combination Immunotherapy, Nature reviews Clinical oncology, 13(5): 273-290. https://doi.org/10.1038/nrclinonc.2016.25 PMid:26977780 PMCid:PMC5551685 Kobayashi T., Shinohara H., Toyoda M., Iwamoto S., and Tanigawa N., 2001, Regression of lymph node metastases by immunotherapy using autologous breast tumor-lysate pulsed dendritic cells: report of a case, Surgery Today, 31: 513-516. https://doi.org/10.1007/s005950170112 PMid:11428604 Kúdelová E., Smolár M., Holubekova V., Hornáková A., Dvorská D., Lucansky V., Koklesová L., Kudela E., and Kubatka P., 2022, Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer, International Journal of Molecular Sciences, 23(23): 14937. https://doi.org/10.3390/ijms232314937 PMid:36499265 PMCid:PMC9735793 Lohmueller J., and Finn O., 2017, Current modalities in cancer immunotherapy: immunomodulatory antibodies, cars and vaccines, Pharmacology and Therapeutics, 178: 31-47. https://doi.org/10.1016/j.pharmthera.2017.03.008 PMid:28322974 PMCid:PMC5600680 Luo C., Wang P., He S., Zhu J., Shi Y., and Wang J., 2022, Progress and prospect of immunotherapy for triple-negative breast cancer, Frontiers in Oncology, 12: 919072. https://doi.org/10.3389/fonc.2022.919072 PMid:35795050 PMCid:PMC9251310 Macri C., and Mintern J., 2019, Cancer immunotherapy: advances and future challenges, Immunology and Cell Biology, 97(4): 353-354. https://doi.org/10.1111/imcb.12250 PMid:31012171 Mina L., Lim S., Bahadur S., and Firoz A., 2019, Immunotherapy for the Treatment of Breast Cancer: Emerging New Data, Breast Cancer : Targets and Therapy, 11: 321-328. https://doi.org/10.2147/BCTT.S184710 PMid:32099454 PMCid:PMC6997226 Monnot G., and Romero P., 2018, Rationale for immunological approaches to breast cancer therapy, Breast, 37: 187-195. https://doi.org/10.1016/j.breast.2017.06.009 PMid:28629632 Nguyen A., Johanning G., and Shi Y., 2022, Emerging novel combined CAR-T cell therapies, Cancers, 14(6): 1403. https://doi.org/10.3390/cancers14061403 PMid:35326556 PMCid:PMC8945996 Pan C., Liu H., Robins E., Song W., Liu D., Li Z., and Zheng L., 2020, Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy, Journal of Hematology and Oncology, 13(1): 29. https://doi.org/10.1186/s13045-020-00862-w PMid:32245497 PMCid:PMC7119170 Raja J., Ludwig J., Gettinger S., Schalper K., and Kim H., 2018, Oncolytic virus immunotherapy: future prospects for oncology, Journal for Immunotherapy of Cancer, 6(1): 140. https://doi.org/10.1186/s40425-018-0458-z PMid:30514385 PMCid:PMC6280382
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==